Cholestyramine Light (Cholestyramine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cholestyramine Light. Always confirm against the full prescribing information.
100 interactions
Amiodarone
The serum concentration of Amiodarone can be decreased when it is combined with Cholestyramine.
Level 1 evidence
Beclomethasone dipropionate
Cholestyramine may increase the excretion rate of Beclomethasone dipropionate which could result in a lower serum level and potentially a reduction in efficacy.
Level 1 evidence
Bendroflumethiazide
Cholestyramine can cause a decrease in the absorption of Bendroflumethiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Betamethasone
Cholestyramine may increase the excretion rate of Betamethasone which could result in a lower serum level and potentially a reduction in efficacy.
Level 1 evidence
Budesonide
Cholestyramine may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Level 1 evidence
Calcifediol
The serum concentration of Calcifediol can be decreased when it is combined with Cholestyramine.
Level 1 evidence
Calcitriol
The serum concentration of Calcitriol can be decreased when it is combined with Cholestyramine.
Level 1 evidence
Chenodeoxycholic acid
Cholestyramine can cause a decrease in the absorption of Chenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 1 evidence
Chlorothiazide
Cholestyramine can cause a decrease in the absorption of Chlorothiazide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Chlorthalidone
Cholestyramine can cause a decrease in the absorption of Chlorthalidone resulting in a reduced serum concentration and potentially a decrease in efficacy.
Level 2 evidence
Cholecalciferol
The serum concentration of Cholecalciferol can be decreased when it is combined with Cholestyramine.
Level 1 evidence
Cholic Acid
Cholestyramine can cause a decrease in the absorption of Cholic Acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cholestyramine Light (Cholestyramine) has 180 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Cholestyramine Light (Cholestyramine) has 4 major, 111 moderate, and 65 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cholestyramine Light. Always confirm against the full prescribing information.